Moreover, a polymorphism in the TLR4 extracellular domain has been reported to be associated with protection against late-onset AD in an Italian population[5], suggesting that a sterile inflammatory response could influence AD pathology through TLR4 signaling. Here, TLR4 is linked to Alzheimer disease.